Structural Network on Prostate Cancer in the French Greater West Region

NCT03214315 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2019-11-05

No results posted yet for this study

Summary

The project aims at developing and structuring a network of clinicians, pathologists, and scientists, from the "Grand Ouest" area, most of them already involved in prostate cancer management and research.

Patients treated by radical prostatectomy will be recruited within the ReSCaP network of clinicians, with centralized database and standardized bio-resource collection, including prostate and adipose tissue samples. Seven clinical centers will participate to the network, 6 recruiting mainly Caucasian patients, and 1 from the French West Indies recruiting mainly African Caribbean patients. After 18 months, 1000 patients will be included.

The main goal is to study the relationships between adipose tissue/lipids and prostate cancer aggressiveness. In fact, adipose tissue is likely to be involved in cancer progression at many levels: abdominal obesity has been associated with aggressive disease, and poly-unsaturated fatty acids (PUFAs), as well as cytokines produced by adipocytes (adipokines) have an impact on cancer cells growth and migration in vitro. Moreover, adipose tissue is the preferential site of storage of persistent organic pollutants with estrogenic properties, which could impact cancer progression.

The study will analyze the association between adipose tissue (distant from the prostate) composition and cancer aggressiveness. Among the 1000 patients, 100 aggressive tumors will be selected according to the d'Amico criteria (Gleason score 8 or more and/or pT3 tumors). They will be matched with 100 potentially indolent prostate cancers (Gleason 6 or less, and PSA less than 10, and pT2 stage on the surgical specimen). These 200 adipose tissue samples will be analyzed for 1/ the lipid profile, including the fatty acid composition, particularly PUFAs, that reflects past dietary fat intake, 2/ adipokine expression, and 3/ tissue concentrations of persistent organic pollutants belonging to the class of organochlorine pesticides with hormone-like activity.

Conditions

Interventions

PROCEDURE

Visceral adipose tissue specimen

specimen

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV
  • Nantes University Hospital

    collaborator OTHER
  • Rennes University Hospital

    collaborator OTHER
  • University Hospital, Angers

    collaborator OTHER_GOV
  • Poitiers University Hospital

    collaborator OTHER
  • Centre Hospitalier Universitaire de la Guadeloupe

    collaborator OTHER
  • University Hospital, Tours

    lead OTHER

Principal Investigators

  • Gaelle FROMONT-HANKARD, MD-PHD · University François Rabelais of TOURS

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-11
Primary Completion
2016-09-27
Completion
2016-09-27

Countries

  • France
  • Guadeloupe

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03214315 on ClinicalTrials.gov